2021
DOI: 10.1111/jocd.13926
|View full text |Cite
|
Sign up to set email alerts
|

Serum angiopoietin‐2 level as a novel potential biomarker in oral lichen planus

Abstract: Background Lichen planus is a common chronic cutaneous inflammatory disease. Recent advances evidenced that angiogenesis is tightly connected to it. More recently, the endothelial specific growth factor angiopoietin‐2 has been clarified to interact with vascular endothelial growth factor. Angiopoietin‐2 level has not been investigated in lichen planus. Aim To evaluate serum level of angiopoietin‐2 in cutaneous and oral lichen planus. Methods Ninety patients were investigated, 45 patients with lichen planus. In… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

2021
2021
2024
2024

Publication Types

Select...
2

Relationship

1
1

Authors

Journals

citations
Cited by 2 publications
(1 citation statement)
references
References 11 publications
0
1
0
Order By: Relevance
“…The upregulation of Ang-2 in endothelial cells could be the initial trigger of vascular expansion in psoriasis [11]. Recent reports have identified the association between serum Ang-2 and the severity of atopic dermatitis and lichen planus [17,18]. Furthermore, the high Ang-2 serum level in psoriasis patients might contribute to the increased cardiovascular risk factors associated with psoriasis suggesting the systemic role of Ang-2 in psoriasis associated comorbidities [19].…”
Section: Discussionmentioning
confidence: 99%
“…The upregulation of Ang-2 in endothelial cells could be the initial trigger of vascular expansion in psoriasis [11]. Recent reports have identified the association between serum Ang-2 and the severity of atopic dermatitis and lichen planus [17,18]. Furthermore, the high Ang-2 serum level in psoriasis patients might contribute to the increased cardiovascular risk factors associated with psoriasis suggesting the systemic role of Ang-2 in psoriasis associated comorbidities [19].…”
Section: Discussionmentioning
confidence: 99%